Cargando…

Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies

Neutralizing antibodies (nAbs) prevent the entry of viruses into permissive cells. Since nAbs represent correlates of protection against the Rabies lyssavirus, the presence of sufficient nAbs indicates effective vaccination. Accordingly, Rabies lyssavirus-specific nAb titers need to be determined in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schöler, Lara, Le-Trilling, Vu Thuy Khanh, Dittmer, Ulf, Fiedler, Melanie, Trilling, Mirko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159627/ https://www.ncbi.nlm.nih.gov/pubmed/35536867 http://dx.doi.org/10.1371/journal.pntd.0010425

Ejemplares similares

A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
por: Schöler, Lara, et al.
Publicado: (2020)

Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2017)

Discrepancy between frequent occurrence of COVID‐19‐like symptoms and low seroconversion rates among healthcare workers
por: Dehnen, Dorothea, et al.
Publicado: (2021)

Cellular Cullin RING Ubiquitin Ligases: Druggable Host Dependency Factors of Cytomegaloviruses
por: Becker, Tanja, et al.
Publicado: (2019)

Mouse Cytomegalovirus M34 Encodes a Non-essential, Nuclear, Early-Late Expressed Protein Required for Efficient Viral Replication
por: Eilbrecht, Mareike, et al.
Publicado: (2020)

A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19
por: Krempe, Friederike, et al.
Publicado: (2021)

A simple algorithm based on initial Ct values predicts the duration to SARS-CoV-2 negativity and allows more efficient test-to-release and return-to-work schedules
por: Anastasiou, Olympia E., et al.
Publicado: (2023)

Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations
por: Klingen, Robin L., et al.
Publicado: (2021)

Exploitation of Herpesviral Transactivation Allows Quantitative Reporter Gene-Based Assessment of Virus Entry and Neutralization
por: Reinhard, Henrike, et al.
Publicado: (2011)

Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI
por: Holtkamp, Caroline, et al.
Publicado: (2022)

Nedd8-Activating Enzyme Is a Druggable Host Dependency Factor of Human and Mouse Cytomegalovirus
por: Flores-Martínez, Yulia Alejandra, et al.
Publicado: (2021)

Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection
por: Bongard, Nadine, et al.
Publicado: (2019)

Deletion of the non-adjacent genes UL148 and UL148D impairs human cytomegalovirus-mediated TNF receptor 2 surface upregulation
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2023)

Deciphering of the Human Interferon-Regulated Proteome by Mass Spectrometry-Based Quantitative Analysis Reveals Extent and Dynamics of Protein Induction and Repression
por: Megger, Dominik A., et al.
Publicado: (2017)

Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses
por: Coertse, Jessica, et al.
Publicado: (2023)

Identification of DNA-Damage DNA-Binding Protein 1 as a Conditional Essential Factor for Cytomegalovirus Replication in Interferon-γ-Stimulated Cells
por: Trilling, Mirko, et al.
Publicado: (2011)

Lyssaviruses and the Fatal Encephalitic Disease Rabies
por: Scott, Terence Peter, et al.
Publicado: (2021)

Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro
por: Bormann, Maren, et al.
Publicado: (2021)

Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus
por: Donnarumma, Tiziano, et al.
Publicado: (2016)

A Pan-Lyssavirus Taqman Real-Time RT-PCR Assay for the Detection of Highly Variable Rabies virus and Other Lyssaviruses
por: Wadhwa, Ashutosh, et al.
Publicado: (2017)

Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2021)

Rabies in the African Civet: An Incidental Host for Lyssaviruses?
por: Sabeta, Claude T., et al.
Publicado: (2020)

STAT2-Dependent Immune Responses Ensure Host Survival despite the Presence of a Potent Viral Antagonist
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2018)

Human Cytomegalovirus-Induced Degradation of CYTIP Modulates Dendritic Cell Adhesion and Migration
por: Grosche, Linda, et al.
Publicado: (2017)

A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa
por: Wright, Edward, et al.
Publicado: (2009)

The Transcription and Translation Landscapes during Human Cytomegalovirus Infection Reveal Novel Host-Pathogen Interactions
por: Tirosh, Osnat, et al.
Publicado: (2015)

Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies
por: Rupprecht, Charles, et al.
Publicado: (2017)

Rabies Infection: An Overview of Lyssavirus-Host Protein Interactions
por: Zandi, Fatemeh, et al.
Publicado: (2021)

Quantification of Lyssavirus-Neutralizing Antibodies Using Vesicular Stomatitis Virus Pseudotype Particles
por: Moeschler, Sarah, et al.
Publicado: (2016)

Detection of Apparent Early Rabies Infection by LN34 Pan-Lyssavirus Real-Time RT-PCR Assay in Pennsylvania
por: Dettinger, Lisa, et al.
Publicado: (2022)

Comprehensive Analysis of Codon Usage on Rabies Virus and Other Lyssaviruses
por: Zhang, Xu, et al.
Publicado: (2018)

Lagos Bat Virus, an Under-Reported Rabies-Related Lyssavirus
por: Coertse, Jessica, et al.
Publicado: (2021)

Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus
por: Shipley, Rebecca, et al.
Publicado: (2022)

Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay
por: Orłowska, Anna, et al.
Publicado: (2020)

Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2022)

Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus
por: Le-Trilling, Vu Thuy Khanh, et al.
Publicado: (2023)

Multi-site evaluation of the LN34 pan-lyssavirus real-time RT-PCR assay for post-mortem rabies diagnostics
por: Gigante, Crystal M., et al.
Publicado: (2018)

Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1
por: Silke Heilingloh, Christiane, et al.
Publicado: (2020)

Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses
por: Weir, Dawn L., et al.
Publicado: (2021)

Molecular Detection of Rabies Lyssaviruses from Dogs in Southeastern Nigeria: Evidence of TransboundaryTransmission of Rabies in West Africa
por: Eze, Ukamaka U, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v448a5l2tmck24bqfk2aoa2hno